Back to Journals » OncoTargets and Therapy » Volume 15

Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian Cancer

Total article views   HTML views PDF downloads Totals
3,700 Dovepress* 3,543+ 152 3,695
PubMed Central* 157 56 213
Totals 3,700 208 3,908
*Since 12 September 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar